These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37938193)

  • 1. Supercharged NK Cell-Based Immuotherapy in Humanized Bone Marrow Liver and Thymus (Hu-BLT) Mice Model of Oral, Pancreatic, Glioblastoma, Hepatic, Melanoma and Ovarian Cancers.
    Kaur K; Jewett A
    Crit Rev Immunol; 2023; 43(2):13-25. PubMed ID: 37938193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice.
    Kaur K; Chen PC; Ko MW; Mei A; Senjor E; Malarkannan S; Kos J; Jewett A
    Front Immunol; 2023; 14():1132807. PubMed ID: 37197660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
    Kozlowska AK; Kaur K; Topchyan P; Jewett A
    Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice.
    Kaur K; Kozlowska AK; Topchyan P; Ko MW; Ohanian N; Chiang J; Cook J; Maung PO; Park SH; Cacalano N; Fang C; Jewett A
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878338
    [No Abstract]   [Full Text] [Related]  

  • 5. NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis.
    Jewett A; Kos J; Fong Y; Ko MW; Safaei T; Perišić Nanut M; Kaur K
    Semin Cancer Biol; 2018 Dec; 53():178-188. PubMed ID: 30081230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy.
    Kaur K; Jewett A
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and Functions.
    Kaur K; Jewett A
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Defects of Natural Killer Cells in Cancer Patients: Anarchy, Dysregulated Systemic Immunity, and Immunosuppression in Metastatic Cancer.
    Jewett A; Kos J; Kaur K; Turnsek TL; Breznik B; Senjor E; Wong P; Nguyen KY; Ko MW
    Crit Rev Immunol; 2020; 40(2):93-133. PubMed ID: 32749091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Gingival NK Cells in Precancerous and Cancerous Stages of Pancreatic Cancer in KC and BLT-Humanized Mice.
    Kaur K; Chang HH; Cook J; Eibl G; Jewett A
    Front Immunol; 2017; 8():1606. PubMed ID: 29255459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors
    Kaur K; Topchyan P; Kozlowska AK; Ohanian N; Chiang J; Maung PO; Park SH; Ko MW; Fang C; Nishimura I; Jewett A
    Oncoimmunology; 2018; 7(5):e1426518. PubMed ID: 29721395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ.
    Kaur K; Sun Y; Kanayama K; Morinaga K; Hokugo A; Nishimura I; Jewett A
    Front Endocrinol (Lausanne); 2023; 14():1111627. PubMed ID: 36742414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy.
    Chiang J; Chen PC; Pham J; Nguyen CQ; Kaur K; Raman SS; Jewett A
    Front Immunol; 2023; 14():1284669. PubMed ID: 37954598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategies to target cancer stem cells by NK cells; studies in humanized mice.
    Kozlowska AK; Kaur K; Topchyan P; Jewett A
    Front Biosci (Landmark Ed); 2017 Jan; 22(2):370-384. PubMed ID: 27814619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity.
    Liu C; Li Y; Li Y; Hu M; Wang H; Lu S; Li Z; Dilimulati D; Jiao S; Lu S; Zhao W
    Immun Inflamm Dis; 2024 Jan; 12(1):e1143. PubMed ID: 38270321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas.
    Kaur K; Sanghu J; Memarzadeh S; Jewett A
    Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
    Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
    Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
    Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Front Immunol; 2018; 9():824. PubMed ID: 29740437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice.
    Kaur K; Chang HH; Topchyan P; Cook JM; Barkhordarian A; Eibl G; Jewett A
    Front Immunol; 2018; 9():1229. PubMed ID: 29977235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis.
    Jewett A; Kos J; Kaur K; Safaei T; Sutanto C; Chen W; Wong P; Namagerdi AK; Fang C; Fong Y; Ko MW
    Mol Ther Oncolytics; 2020 Mar; 16():41-52. PubMed ID: 31930165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor.
    Kaur K; Safaie T; Ko MW; Wang Y; Jewett A
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33440654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.